140 related articles for article (PubMed ID: 3005214)
1. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
Watanabe Y; Tawara S; Mine Y; Kikuchi H
J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
[TBL] [Abstract][Full Text] [Related]
2. Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
Mine Y; Watanabe Y; Tawara S; Yokota Y; Nishida M; Goto S; Kuwahara S
J Antibiot (Tokyo); 1983 Aug; 36(8):1059-66. PubMed ID: 6630057
[TBL] [Abstract][Full Text] [Related]
3. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
[TBL] [Abstract][Full Text] [Related]
4. Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
Yokota Y; Mine Y; Wakai Y; Watanabe Y; Nishida M; Goto S; Kuwahara S
J Antibiot (Tokyo); 1983 Aug; 36(8):1051-8. PubMed ID: 6415030
[TBL] [Abstract][Full Text] [Related]
5. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
[TBL] [Abstract][Full Text] [Related]
6. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
Mine Y; Yokota Y; Wakai Y; Fukada S; Nishida M; Goto S; Kuwahara S
J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
[TBL] [Abstract][Full Text] [Related]
7. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
[No Abstract] [Full Text] [Related]
8. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.
Takeno H; Okada S; Hemmi K; Aratani M; Kitaura Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2925-31. PubMed ID: 6518578
[No Abstract] [Full Text] [Related]
9. Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
Schultz RM; Altom MG
J Immunopharmacol; 1986; 8(4):515-28. PubMed ID: 3543138
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
Inamura N; Nakahara K; Kino T; Gotoh T; Kawamura I; Aoki H; Imanaka H; Sone S
J Biol Response Mod; 1985 Aug; 4(4):408-17. PubMed ID: 4031951
[TBL] [Abstract][Full Text] [Related]
11. In vivo activation of functional properties in mouse peritoneal macrophages by Nocardia rubra cell wall skeleton.
Mine Y; Watanabe Y; Tawara S; Nonoyama S; Yokota Y; Kikuchi H
Arzneimittelforschung; 1986 Nov; 36(11):1651-5. PubMed ID: 3028437
[TBL] [Abstract][Full Text] [Related]
12. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Ahmed K; Turk JL
Cancer Immunol Immunother; 1989; 28(2):87-92. PubMed ID: 2783891
[TBL] [Abstract][Full Text] [Related]
13. Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.
Gotoh T; Nakahara K; Nishiura T; Hashimoto M; Kino T; Kuroda Y; Okuhara M; Kohsaka M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1982 Oct; 35(10):1286-92. PubMed ID: 6757224
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.
Izumi S; Nakahara K; Gotoh T; Hashimoto S; Kino T; Okuhara M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1983 May; 36(5):566-74. PubMed ID: 6192122
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
[No Abstract] [Full Text] [Related]
16. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156.
Takeno H; Okada S; Yonishi S; Hemmi K; Nakaguchi O; Kitaura Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2932-41. PubMed ID: 6518579
[No Abstract] [Full Text] [Related]
17. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages.
Mauel J; Van Pham T; Kreis B; Bauer J
Int J Immunopharmacol; 1989; 11(6):637-45. PubMed ID: 2553625
[TBL] [Abstract][Full Text] [Related]
18. Studies on a new immunoactive peptide, FK-156. IV. Synthesis of FK-156 and its geometric isomer.
Hemmi K; Aratani M; Takeno H; Okada S; Miyazaki Y; Nakaguchi O; Kitaura Y; Hashimoto M
J Antibiot (Tokyo); 1982 Oct; 35(10):1300-11. PubMed ID: 7174517
[TBL] [Abstract][Full Text] [Related]
19. The role of superoxide anion and lysosomal enzymes in anti-listerial activity of elicited peritoneal macrophages.
Hashimoto S; Nomoto K; Yokokura T
Scand J Immunol; 1986 Oct; 24(4):429-36. PubMed ID: 3020680
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in mice.
Suzuki I; Kinoshita A; Tanaka H; Yadomae T
Int J Immunopharmacol; 1991; 13(2-3):147-54. PubMed ID: 2071291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
